drugset / Trial / NCT00420498
Effects of Atomoxetine on Cognitive Function in Schizophrenia
Phase 2
Completed
12 enrolled
Yale University
National Alliance for Research on Schizophrenia and Depression · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to examine the effects of atomoxetine (Strattera™) on prefrontal cognitive functioning in persons with schizophrenia. Secondarily, the effects of atomoxetine on positive and negative symptoms and on cigarette smoking consumption in persons with schizophrenia will be examined.
Timeline
- Start
- 2005-08
- Primary completion
- —
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atomoxetine | Other / unclassified | 40 mg | — |
| Subject | Atomoxetine | Other / unclassified | 80 mg | — |